$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Abstract AI-Helper 아이콘AI-Helper

AbstractToll‐like receptors (TLRs) are pattern recognition receptors that play an important role in host defence by recognizing pathogen‐associated molecular patterns (PAMP). Recent studies indicate that TLR signalling plays an important role in progression of chronic liver diseases. Ong...

주제어

참고문헌 (124)

  1. Aderem A , Ulevitch RJ . Toll‐like receptors in the induction of the innate immune response . Nature 2000 ; 406 : 782 – 7 . 

  2. Beutler BA . TLRs and innate immunity . Blood 2009 ; 113 : 1399 – 407 . 

  3. Akira S , Takeda K . Toll‐like receptor signalling . Nat Rev Immunol 2004 ; 4 : 499 – 511 . 

  4. Botos I , Segal DM , Davies DR . The structural biology of Toll‐like receptors . Structure 2011 ; 19 : 447 – 59 . 

  5. Kumar H , Kawai T , Akira S . Toll – like receptors and innate immunity . Biochem Biophys Res Commun 2009 ; 388 : 621 – 5 . 

  6. Babu S , Blauvelt CP , Kumaraswami V , Nutman TB . Cutting edge: diminished T cell TLR expression and function modulates the immune response in human filarial infection . J Immunol 2006 ; 176 : 3885 – 9 . 

  7. Pradere JP , Troeger JS , Dapito DH , Mencin AA , Schwabe RF . Toll‐like receptor 4 and hepatic fibrogenesis . Semin Liver Dis 2010 ; 30 : 232 – 44 . 

  8. O'Neill LA . The interleukin‐1 receptor/Toll‐like receptor superfamily: 10 years of progress . ImmunolRev 2008 ; 226 : 10 – 8 . 

  9. Harju K , Glumoff V , Hallman M . Ontogeny of Toll‐like receptors Tlr2 and Tlr4 in mice . Pediatr Res 2001 ; 49 : 81 – 3 . 

  10. Wheeler DS , Chase MA , Senft AP , et?al . Extracellular Hsp72, an endogenous DAMP, is released by virally infected airway epithelial cells and activates neutrophils via Toll‐like receptor (TLR)‐4 . Respir Res 2009 ; 10 : 31 . 

  11. Leadbetter EA , Rifkin IR , Hohlbaum AM , et?al . Chromatin‐IgG complexes activate B cells by dual engagement of IgM and Toll‐like receptors . Nature 2002 ; 416 : 603 – 7 . 

  12. Wang W , Xu GL , Jia WD , et?al . Ligation of TLR2 by versican: a link between inflammation and metastasis . Arch Med Res 2009 ; 40 : 321 – 3 . 

  13. Park JS , Svetkauskaite D , He Q , et?al . Involvement of toll‐like receptors 2 and 4 in cellular activation by high mobility group box 1 protein . J BiolChem 2004 ; 279 : 7370 – 7 . 

  14. Tsan MF , Gao B . Endogenous ligands of Toll‐like receptors . J Leukoc Biol 2004 ; 76 : 514 – 9 . 

  15. Chuang T , Ulevitch RJ . Identification of hTLR10: a novel human Toll‐like receptor preferentially expressed in immune cells . Biochim Biophys Acta 2001 ; 1518 : 157 – 61 . 

  16. Guan Y , Ranoa DR , Jiang S , et?al . Human TLRs 10 and 1 share common mechanisms of innate immune sensing but not signaling . J Immunol 2010 ; 184 : 5094 – 103 . 

  17. Bourke E , Bosisio D , Golay J , Polentarutti N , Mantovani A . The toll‐like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells . Blood 2003 ; 102 : 956 – 63 . 

  18. Testro AG , Visvanathan K . Toll‐like receptors and their role in gastrointestinal disease . J Gastroenterol Hepatol 2009 ; 24 : 943 – 54 . 

  19. Chuang TH , Ulevitch RJ . Triad 3A, an E3 ubiquitin – protein lipase regulating Toll Like receptors . Nat Immunol 2004 ; 5 : 495 – 502 . 

  20. Divanovic S , Trompette A , Atabani SF , et?al . Negative regulation of Toll‐like receptor 4 signaling by the Toll‐like receptor homolog RP105 . Nat Immunol 2005 ; 6 : 571 – 8 . 

  21. Iwami KI , Matsuguchi T , Masuda A , et?al . Cutting edge: naturally occurring soluble form of mouse Toll‐like receptor 4 inhibits lipopolysaccharide signaling . J Immunol 2000 ; 165 : 6682 – 6 . 

  22. Wald D , Qin J , Zhao Z , et?al . SIGIRR, a negative regulator of Toll‐like receptor‐interleukin 1 receptor signaling . Nat Immunol 2003 ; 4 : 920 – 7 . 

  23. Janssens S , Burns K , Tschopp J , Beyaert R . Regulation of interleukin‐1‐ and lipopolysaccharide‐induced NF‐kappaB activation by alternative splicing ofMyD88 . Curr Biol 2002 ; 12 : 467 – 71 . 

  24. An H , Hou J , Zhou J , et?al . Phosphatase SHP‐1 promotes TLR‐ and RIG‐I‐activated production of type I interferon by inhibiting the kinase IRAK1 . Nat Immunol 2008 ; 9 : 542 – 50 . 

  25. Saitoh T , Tun‐Kyi A , Ryo A , et?al . Negative regulation of interferon‐regulatory factor 3‐dependent innate antiviralresponse by the prolyl isomerase Pin1 . Nat Immunol 2006 ; 7 : 598 – 605 . 

  26. Nakagawa R , Naka T , Tsutsui H , et?al . SOCS‐1 participates in negative regulation of LPS responses . Immunity 2002 ; 17 : 677 – 87 . 

  27. Gon Y , Asai Y , Hashimoto S , et?al . A20 inhibits toll‐like receptor 2‐ and 4‐mediated interleukin‐8 synthesis in airway epithelial cells . Am J Respir Cell MolBiol 2004 ; 31 : 330 – 6 . 

  28. Wang C , Chen T , Zhang J , et?al . The E3 ubiquitin ligase Nrdp1 ‘preferentially’ promotes TLR‐mediated production of type I interferon . Nat Immunol 2009 ; 10 ( 7 ): 744 – 52 . 

  29. Yoshida H , Jono H , Kai H , LiJ D . The tumor suppressor cylindromatosis (CYLD) acts as a negative regulator for toll‐like receptor 2 signaling via negative cross‐talk with TRAF6 AND TRAF7 . J BiolChem 2005 ; 280 : 41111 – 21 . 

  30. Kobayashi K , Hernandez LD , Galan JE , et?al . IRAK‐M is a negative regulator of Toll‐like receptor signaling . Cell 2002 ; 110 : 191 – 202 . 

  31. Diehl GE , Yue HH , Hsieh K , et?al . TRAIL‐R as a negative regulator of innate immune cellresponses . Immunity 2004 ; 21 : 877 – 89 . 

  32. Kuwata H , Watanabe Y , Miyoshi H , et?al . IL‐10‐inducible Bcl‐3 negatively regulates LPS‐induced TNFalpha production in macrophages . Blood 2003 ; 102 : 4123 – 9 . 

  33. Hayashi F , Smith KD , Ozinsky A , et?al . The innate immune response to bacterialflagellin is mediated by Toll‐like receptor 5 . Nature 2001 ; 410 : 1099 – 103 . 

  34. Hemmi H , Takeuchi O , Kawai T , et?al . A Toll‐like receptor recognizes bacterial DNA . Nature 2000 ; 408 : 740 – 5 . 

  35. Yoneyama M , Kikuchi M , Matsumoto K , et?al . Shared and unique functions of the DExD/H‐box helicases RIG‐I, MDA5, and LGP2 in antiviral innate immunity . J Immunol 2005 ; 175 : 2851 – 8 . 

  36. Liu S , Gallo DJ , Green AM , et?al . Role of toll‐like receptors in changes in gene expression and NFkappa B activation in mouse hepatocytes stimulated with lipopolysaccharide . Infect Immun 2002 ; 70 : 3433 – 42 . 

  37. Scott MJ , Billiar TR . Beta2‐integrin‐induced p38 MAPK activation is a key mediator in theCD14/TLR4/MD2‐dependent uptake of lipopolysaccharide by hepatocytes . J BiolChem 2008 ; 283 : 29433 – 46 . 

  38. Thobe BM , Frink M , Hildebrand F , et?al . The role ofMAPK in Kupffer cell toll‐like receptor (TLR) 2‐, TLR4‐, and TLR9‐mediated signaling following trauma‐hemorrhage . J Cell Physiol 2007 ; 210 : 667 – 75 . 

  39. Jiang W , Sun R , Wei H , Tian Z . Toll‐like receptor 3 ligand attenuates LPS‐induced liver injury by downregulation of toll‐like receptor 4 expression on macrophages . Proc Natl Acad Sci U S A 2005 ; 102 : 17077 – 82 . 

  40. Schwabe RF , Seki E , Brenner DA . Toll‐like receptor signaling in the liver . Gastroenterology 2006 ; 130 : 1886 – 900 . 

  41. Su GL . Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation . Am J Physiol Gastrointest Liver Physiol 2002 ; 283 : G256 – 65 . 

  42. Knolle P , Schlaak J , Uhrig A , et?al . Human Kupffer cells secrete IL‐10 in response to lipopolysaccharide (LPS) challenge . J Hepatol 1995 ; 22 : 226 – 9 . 

  43. Brun P , Castagliuolo I , Pinzani M , Palu G , Martines D . Exposure to bacterial cell wall products triggers anti nflammatory phenotype in hepatic stellate cells . Am J Physiol Gastrointest Liver Physiol 2005 ; 289 : G571 – 8 . 

  44. Gabele E , Muhlbauer M , Dorn C , et?al . Role of TLR9 in hepatic stellate cells and experimental liver fibrosis . Biochem Biophys Res Commun 2008 ; 376 : 271 – 6 . 

  45. Rivera CA , Adegboyega P , van Rooijen N , et?al . Toll‐like receptor‐4signaling and Kupffer cells play pivotalroles in the pathogenesis of non‐alcoholic steatohepatitis . J Hepatol 2007 ; 47 : 571 – 9 . 

  46. Guo J , Friedman SL . Toll‐like receptor 4 signaling in liver injury and hepatic fibrogenesis . Fibrogenesis Tissue Repair 2010 ; 3 : 21 . 

  47. Harada K , Ohira S , Isse K , et?al . Lipopolysaccharide activates nuclear factor‐kappaB through toll‐likereceptors and related molecules in cultured biliary epithelial cells . Lab Invest 2003 ; 83 : 1657 – 67 . 

  48. Harada K , Isse K , Nakanuma Y . Interferon gamma accelerates NF‐kappaB activation of biliary epithelial cells induced by Toll‐like receptor and ligand interaction . J Clin Pathol 2006 ; 59 : 184 – 90 . 

  49. Martin‐Armas M , Simon‐Santamaria J , Pettersen I , et?al . Toll‐likereceptor 9 (TLR9) is present in murine liver sinusoidal endothelial cells (LSECs) and mediates the effect ofCpG‐oligonucleotides . J Hepatol 2006 ; 44 : 939 – 46 . 

  50. Uhrig A , Banafsche R , Kremer M , et?al . Development and functional consequences of LPS tolerance in sinusoidal endothelial cells of the liver . J Leukoc Biol 2005 ; 77 : 626 – 33 . 

  51. Lohse AW , Knolle PA , Bilo K , et?al . Antigen‐presenting function and B7 expression of murine sinusoidal endothelial cells and Kupffer cells . Gastroenterology 1996 ; 110 : 1175 – 81 . 

  52. Schmidt KN , Leung B , Kwong M , et?al . APC independent activation of NK cells by the Toll‐like receptor 3 agonist double‐stranded RNA . J Immunol 2004 ; 172 : 138 . 

  53. Sivori S , Falco M , Della Chiesa M , et?al . CpG and double‐stranded RNA trigger human NK cells by Toll‐like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells . Proc Natl Acad Sci U S A 2004 ; 101 : 10116 – 21 . 

  54. Chalifour A , Jeannin P , Gauchat JF , et?al . Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers alpha‐defensin production . Blood 2004 ; 104 : 1778 – 83 . 

  55. Gorski KS , Waller EL , Bjornton‐Severson J , et?al . Distinct indirect pathways govern human NK‐cellactivation by TLR‐7 and TLR‐8 agonists . Int Immunol 2006 ; 18 : 1115 – 26 . 

  56. Meyer‐Bahlburg A , Khim S , Rawlings DJ . B cell intrinsic TLR signals amplify but are not required for humoral immunity . J Exp Med 2007 ; 204 : 3095 – 101 . 

  57. Zanin‐Zhorov A , Tal‐Lapidot G , Cahalon L , et?al . Cutting edge: T cells respond to lipopolysaccharide innately via TLR4 signaling . J Immunol 2007 ; 179 : 41 – 4 . 

  58. De Creus A , Abe M , Lau AH , et?al . Low TLR4 expression by liver dendritic cells correlates with reduced capacity to activate allogeneic T cells in response to endotoxin . J Immunol 2005 ; 174 : 2037 – 45 . 

  59. Seki E , Brenner DA . Toll‐like receptors and adaptor molecules in liver disease: update . Hepatology 2008 ; 48 : 322 – 35 . 

  60. Szabo G , Dolganiuc A , Mandrekar P . Pattern recognition receptors: a contemporary view on liverdiseases . Hepatology 2006 ; 44 : 287 – 98 . 

  61. Chen Y , Sun R . Toll‐like receptors in acute liver injury and regeneration . Int Immunopharmacol 2011 ; 11 : 1433 – 41 . 

  62. Petrasek J , Mandrekar P , Szabo G . Toll‐like receptors in the pathogenesis of alcoholic liver disease . Gastroenterol Res Pract 2010 ; 2010 : 710381 . 

  63. Younossi ZM , Venkatesan C . A 2012 clinical update for internists in adult nonalcoholic fatty liverdisease . Panminerva Med 2012 ; 54 : 29 – 37 . 

  64. Harte AL , da Silva NF , Creely SJ , et?al . Elevated endotoxin levels in non‐alcoholic fatty liver disease . J Inflamm (Lond) 2010 ; 7 : 15 . 

  65. Thuy S , Ladurner R , Volynets V , et?al . Nonalcoholic fatty liver disease in humans is associated withincreased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake . J Nutr 2008 ; 138 : 1452 – 5 . 

  66. Brun P , Castagliuolo I , Di Leo V , et?al . Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis . Am J Physiol Gastrointest Liver Physiol 2007 ; 292 : G518 – 25 . 

  67. Li Z , Yang S , Lin H , et?al . Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease . Hepatology 2003 ; 37 : 343 – 50 . 

  68. Tan HH , FielM I , Sun Q , et?al . Kupffer cell activation by ambient air particulate matter exposure may exacerbate non‐alcoholic fatty liver disease . J Immunotoxicol 2009 ; 6 : 266 – 75 . 

  69. Miura K , Kodama Y , Inokuchi S , et?al . Toll‐like receptor 9 promotes steatohepatitis by induction of interleukin‐1beta in mice . Gastroenterology 2010 ; 139 : 323 , 34.e7. 

  70. Himes RW , Smith CW . Tlr2 is criticalfor diet‐induced metabolic syndrome in a murine model . FASEB J 2010 ; 24 : 731 – 9 . 

  71. Szabo G , Velayudham A , Romics L Jr , Mandrekar P . Modulation of non‐alcoholic steatohepatitis by pattern recognition receptors in mice: the role of toll‐like receptors 2 and 4 . Alcohol Clin Exp Res 2005 ; 29 : 140S – 5S . 

  72. O'Shea RS , Dasarathy S , McCullough AJ . Practice Guideline Committee of the American Association for the Study of Liver Diseases, Practice Parameters Committee of the American College of Gastroenterology alcoholic liver disease . Hepatology 2010 ; 51 : 307 – 28 . 

  73. Rao R . Endotoxemia and gut barrier dysfunction in alcoholic liver disease . Hepatology 2009 ; 50 : 638 – 44 . 

  74. Bjarnason I , Peters TJ , Wise RJ . The leaky gut of alcoholism: possible route of entry for toxic compounds . Lancet 1984 ; 1 : 179 – 82 . 

  75. Adachi Y , Moore LE , Bradford BU , Gao W , Thurman RG . Antibiotics prevent liver injury in rats following long‐term exposure to ethanol . Gastroenterology 1995 ; 108 : 218 – 24 . 

  76. Nanji AA , Khettry U , Sadrzadeh SM . Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease) . Proc Soc Exp Biol Med 1994 ; 205 : 243 – 7 . 

  77. Machida K . TLRs, Alcohol, HCV, and Tumorigenesis . Gastroenterol Res Pract 2010 ; 2010 : 518674 . 

  78. Gao B , Seki E , Brenner DA , et?al . Innate immunity in alcoholic liver disease . Am J Physiol Gastrointest Liver Physiol 2011 ; 300 : G516 – 25 . 

  79. Poltorak A , He X , Smirnova I , et?al . Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene . Science 1998 ; 282 : 2085 – 8 . 

  80. Yin M , Bradford BU , Wheeler MD , et?al . Reduced early alcohol‐induced liver injury in CD14‐deficient mice . J Immunol 2001 ; 166 : 4737 – 42 . 

  81. Hritz I , Mandrekar P , Velayudham A , et?al . The critical role of toll‐like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88 . Hepatology 2008 ; 48 : 1224 – 31 . 

  82. Gustot T , Lemmers A , Moreno C , et?al . Differential liver sensitization to toll‐like receptor pathways in mice with alcoholic fatty liver . Hepatology 2006 ; 43 : 989 – 1000 . 

  83. McQuillan GM , Coleman PJ , Kruszon‐Moran D , et?al . Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994 . Am J Public Health 1999 ; 89 : 14 – 8 . 

  84. Keskinen P , Nyqvist M , Sareneva T , et?al . Impaired antiviralresponse in human hepatoma cells . Virology 1999 ; 263 : 364 – 75 . 

  85. Xia C , Lu M , Zhang Z , et?al . TLRs antiviral effect on hepatitis B virus in HepG2 cells . J Appl Microbiol 2008 ; 105 : 1720 – 7 . 

  86. Guo H , Jiang D , Ma D , et?al . Activation of pattern recognition receptor‐mediated innate immunity inhibits the replication of hepatitis B virus in human hepatocyte‐derived cells . J Virol 2009 ; 83 : 847 – 58 . 

  87. Isogawa M , Robek MD , Furuichi Y , Chisari FV . Toll‐like receptor signaling inhibits hepatitis B virus replication in vivo . J Virol 2005 ; 79 : 7269 – 72 . 

  88. Visvanathan K , Skinner NA , Thompson AJ , et?al . Regulation of Toll‐like receptor‐2 expression in chronic hepatitis B by the precore protein . Hepatology 2007 ; 45 : 102 – 10 . 

  89. Abe T , Kaname Y , Hamamoto I , et?al . Hepatitis C virus nonstructural protein 5A modulates the toll‐like receptor‐MyD88‐dependent signaling pathway in macrophage cell lines . J Virol 2007 ; 81 : 8953 – 66 . 

  90. Dolganiuc A , Oak S , Kodys K , et?al . Hepatitis C core and nonstructural 3 proteins trigger toll‐like receptor 2‐mediated pathways and inflammatory activation . Gastroenterology 2004 ; 127 : 1513 – 24 . 

  91. Wang JP , Zhang Y , Wei X , et?al . Circulating Toll‐like receptor (TLR) 2, TLR4, and regulatory T cells in patients with chronic hepatitis C . APMIS 2010 ; 118 : 261 – 70 . 

  92. Sato K , Ishikawa T , Okumura A , et?al . Expression of Toll‐like receptors in chronic hepatitis C virus infection . J Gastroenterol Hepatol 2007 ; 22 : 1627 – 32 . 

  93. Chang S , Kodys K , Szabo G . Impaired expression and function of toll‐like receptor 7 in hepatitis C virus infection in human hepatoma cells . Hepatology 2010 ; 51 : 35 – 42 . 

  94. Kaukinen P , Sillanpaa M , Kotenko S , et?al . Hepatitis C virus NS2 and NS3/4A proteins are potent inhibitors of host cell cytokine/chemokine gene expression . Virol J 2006 ; 3 : 66 . 

  95. Foy E , Li K , Wang C , et?al . Regulation of interferon regulatory factor‐3 by the hepatitis C virus serine protease . Science 2003 ; 300 : 1145 – 8 . 

  96. Ferreon JC , Ferreon AC , Li K , Lemon SM . Molecular determinants of TRIF proteolysis mediated by the hepatitis C virus NS3/4A protease . J Biol Chem 2005 ; 280 : 20483 – 92 . 

  97. Horsmans Y , Berg T , Desager JP , et?al . Isatoribine, an agonist of TLR7, reduces plasma virus concentration in chronic hepatitis C infection . Hepatology 2005 ; 42 : 724 – 31 . 

  98. Kawai T , Sato S , Ishii KJ , et?al . Interferon‐alpha induction through Toll‐like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6 . Nat Immunol 2004 ; 5 : 1061 – 8 . 

  99. Schott E , Witt H , Neumann K , et?al . A Toll‐like receptor 7 single nucleotide polymorphism protects from advanced inflammation and fibrosis in male patients with chronic HCV‐infection . J Hepatol 2007 ; 47 : 203 – 11 . 

  100. Li Y , Chang M , Abar O , et?al . Multiple variants in toll‐like receptor 4 gene modulate risk of liver fibrosis in Caucasians with chronic hepatitis C infection . J Hepatol 2009 ; 51 : 750 – 7 . 

  101. Chuang YH , Lian ZX , Tsuneyama K , et?al . Increased killing activity and decreased cytokine production in NK cells in patients with primary biliary cirrhosis . J Autoimmun 2006 ; 26 : 232 – 40 . 

  102. Shimoda S , Harada K , Niiro H , et?al . Interaction between Toll‐like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosis . Hepatology 2011 ; 53 : 1270 – 81 . 

  103. Wang AP , Migita K , Ito M , et?al . Hepatic expression of toll‐like receptor 4 in primary biliary cirrhosis . J Autoimmun 2005 ; 25 : 85 – 91 . 

  104. Butler P , Hamilton‐Miller JM , McIntyre N , Burroughs AK . Natural history of bacteriuria in women with primary biliary cirrhosis and the effect of antimicrobial therapy in symptomatic and asymptomatic groups . Gut 1995 ; 36 : 931 – 4 . 

  105. Mao TK , Lian ZX , Selmi C , et?al . Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis . Hepatology 2005 ; 42 : 802 – 8 . 

  106. Takii Y , Nakamura M , Ito M , et?al . Enhanced expression of type I interferon and toll‐like receptor‐3 in primary biliary cirrhosis . Lab Invest 2005 ; 85 : 908 – 20 . 

  107. Kikuchi K , Lian ZX , Yang GX , et?al . BacterialCpG induces hyper‐IgM production in CD27(+) memory B cells in primary biliary cirrhosis . Gastroenterology 2005 ; 128 : 304 – 12 . 

  108. Chapman R , Fevery J , Kalloo A , et?al . Diagnosis and management of primary sclerosing cholangitis . Hepatology 2010 ; 51 : 660 – 78 . 

  109. Xu B , Broome U , Ericzon BG , Sumitran‐Holgersson S . High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6 . Gut 2002 ; 51 : 120 – 7 . 

  110. Karrar A , Broome U , Sodergren T , et?al . Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis . Gastroenterology 2007 ; 132 : 1504 – 14 . 

  111. Lang KS , Georgiev P , Recher M , et?al . Immunoprivileged status of the liver is controlled by Toll‐like receptor 3 signaling . J Clin Invest 2006 ; 116 : 2456 – 63 . 

  112. Seki E , De Minicis S , Osterreicher CH , et?al . TLR4 enhances TGF‐beta signaling and hepatic fibrosis . Nat Med 2007 ; 13 : 1324 – 32 . 

  113. Aoyama T , Paik YH , Seki E . Toll‐like receptor signaling and liver fibrosis . Gastroenterol Res Pract 2010 ; 2010 : 192543 . 

  114. Guo J , Loke J , Zheng F , et?al . Functional linkage of cirrhosis‐predictive single nucleotide polymorphisms of Toll‐like receptor 4 to hepatic stellate cellresponses . Hepatology 2009 ; 49 : 960 – 8 . 

  115. Duffield JS , Forbes SJ , Constandinou CM , et?al . Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair . J Clin Invest 2005 ; 115 : 56 – 65 . 

  116. Jeong WI , Park O , Gao B . Abrogation of the antifibrotic effects of natural killer cells/interferon‐gamma contributes to alcohol acceleration of liver fibrosis . Gastroenterology 2008 ; 134 : 248 – 58 . 

  117. Paik YH , Lee KS , Lee HJ , et?al . Hepatic stellate cells primed with cytokines upregulate inflammation in response to peptidoglycan or lipoteichoic acid . Lab Invest 2006 ; 86 : 676 – 86 . 

  118. El‐Serag HB , Rudolph KL . Hepatocellular carcinoma: epidemiology and molecular carcinogenesis . Gastroenterology 2007 ; 132 : 2557 – 76 . 

  119. Maeda S . NF‐kappaB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis . Gastroenterol Res Pract 2010 ; 2010 : 367694 . 

  120. Machida K , Tsukamoto H , Mkrtchyan H , et?al . Toll‐like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog . Proc Natl Acad Sci U S A 2009 ; 106 : 1548 – 53 . 

  121. Dapito DH , Mencin A , Gwak GY , et?al . Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4 . Cancer Cell 2012 ; 21 : 504 – 16 . 

  122. Daubeuf B , Mathison J , Spiller S , et?al . TLR4/MD‐2 monoclonal antibody therapy affords protection in experimental models ofseptic shock . J Immunol 2007 ; 179 : 6107 – 14 . 

  123. Kanzler H , Barrat FJ , Hessel EM , Coffman RL . Therapeutic targeting of innate immunity with Toll‐like receptor agonists and antagonists . Nat Med 2007 ; 13 : 552 – 9 . 

  124. Lin H , Xiao Y , Chen G , et?al . HMG‐CoA reductase inhibitor simvastatin suppresses Toll‐like receptor 2 ligand‐induced activation of nuclear factor kappa B by preventing RhoA activation in monocytes fromrheumatoid arthritis patients . Rheumatol Int 2011 ; 31 : 1451 – 8 . 

관련 콘텐츠

오픈액세스(OA) 유형

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로